Expression of AgNOR in Benign, Borderline and Malignant Epithelial Tumors of Ovary and Its Correlation with Tumor Grading

Background: Surface epithelial tumor is the most common type of ovarian tumor making up 65% of all ovarian neoplasms. The proliferative activity of tumor can be estimated by many methods and the analysis of silver binding nucleolar organizer region (AgNOR) is one of them. Two types of AgNOR counts were calculated – mAgNOR and pAgNOR. Objective: To find out expression of AgNOR staining in benign, borderline and malignant epithelial tumors of ovary and its correlation with tumor grading. Materials and Methods: This cross-sectional study was conducted in the department of Pathology, Sir Salimullah Medical College, Dhaka from March 2018 to July 2020. In this study 70 diagnosed cases of benign, borderline and malignant epithelial tumors of ovary were enrolled. Corresponding paraffin blocks were collected. Ethical practice was ensured in every step of the study. Statistical analysis was carried out as required. Statistical significance was considered at <0.05. Results: Most of the patients were in 31−40 years age group. Most commonly observed epithelial tumors were benign in nature followed by malignant tumors and only two cases were borderline. The mean mAgNOR in malignant tumors was 3.62±0.57, with benign tumors was 1.68±0.53 and with borderline tumors was 1.65±0.21. Progressive increase in AgNOR expression was noted from benign to malignant epithelial ovarian tumors. The mean mAgNOR found in Grade I, Grade II and Grade III were 3.29±0.37, 3.76±0.59 and 4.33±0.15 respectively. Significant differences were found among the all groups and when compared between Grade I and Grade II, also between Grade I and Grade III. The mean pAgNOR found in Grade I, Grade II and Grade III were 13.54±3.05, 16.19±4.35 and 21.33±1.15 respectively. Significant differences were found among the groups and also when compared between Grade I and Grade III. There was significant positive correlation between histological grading of ovarian tumor with mAgNOR (r=0.589; p=0.001) and with pAgNOR (r=0.510; p=0.003). Conclusion: mAgNOR and pAgNOR expressions were significantly elevated in malignant tumors compared to benign and borderline tumors. mAgNOR and pAgNOR are useful markers of cellular kinetics and good prognostic factors in epithelial tumors of ovary. J Enam Med Col 2022; 12(1): 29−35

Authors

Institutions

Publication Details

Journal
Journal of Enam Medical College
Published
2024-09-22
DOI
https://doi.org/10.3329/jemc.v12i1.71691
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expression of AgNOR in Benign, Borderline and Malignant Epithelial Tumors of Ovary and Its Correlation with Tumor Grading

Afroz Shirin, Munmun Pervin, Enamul Kabir, Nasimul Islam
Journal of Enam Medical College
Ovarian cancer diagnosis and treatment
article

Expression of AgNOR in Benign, Borderline and Malignant Epithelial Tumors of Ovary and Its Correlation with Tumor Grading

Afroz Shirin, Munmun Pervin, Enamul Kabir, Nasimul Islam
article en

Abstract

Background: Surface epithelial tumor is the most common type of ovarian tumor making up 65% of all ovarian neoplasms. The proliferative activity of tumor can be estimated by many methods and the analysis of silver binding nucleolar organizer region (AgNOR) is one of them. Two types of AgNOR counts were calculated – mAgNOR and pAgNOR. Objective: To find out expression of AgNOR staining in benign, borderline and malignant epithelial tumors of ovary and its correlation with tumor grading. Materials and Methods: This cross-sectional study was conducted in the department of Pathology, Sir Salimullah Medical College, Dhaka from March 2018 to July 2020. In this study 70 diagnosed cases of benign, borderline and malignant epithelial tumors of ovary were enrolled. Corresponding paraffin blocks were collected. Ethical practice was ensured in every step of the study. Statistical analysis was carried out as required. Statistical significance was considered at <0.05. Results: Most of the patients were in 31−40 years age group. Most commonly observed epithelial tumors were benign in nature followed by malignant tumors and only two cases were borderline. The mean mAgNOR in malignant tumors was 3.62±0.57, with benign tumors was 1.68±0.53 and with borderline tumors was 1.65±0.21. Progressive increase in AgNOR expression was noted from benign to malignant epithelial ovarian tumors. The mean mAgNOR found in Grade I, Grade II and Grade III were 3.29±0.37, 3.76±0.59 and 4.33±0.15 respectively. Significant differences were found among the all groups and when compared between Grade I and Grade II, also between Grade I and Grade III. The mean pAgNOR found in Grade I, Grade II and Grade III were 13.54±3.05, 16.19±4.35 and 21.33±1.15 respectively. Significant differences were found among the groups and also when compared between Grade I and Grade III. There was significant positive correlation between histological grading of ovarian tumor with mAgNOR (r=0.589; p=0.001) and with pAgNOR (r=0.510; p=0.003). Conclusion: mAgNOR and pAgNOR expressions were significantly elevated in malignant tumors compared to benign and borderline tumors. mAgNOR and pAgNOR are useful markers of cellular kinetics and good prognostic factors in epithelial tumors of ovary. J Enam Med Col 2022; 12(1): 29−35

Journal of Enam Medical CollegeVol. 12(1)
St Savas Hospital (GR), Dhaka Medical College and Hospital (BD)
Openalex Percentile: Top 66%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.